Literature DB >> 3792083

Secundum atrial septal defect with severe pulmonary hypertension. Open lung biopsy diagnosis of operative indication.

S Yamaki, T Horiuchi, M Miura, K Haneda, E Ishizawa, Y Suzuki.   

Abstract

In 14 of 15 patients ranging in age from 1 to 62 years (mean of 34) with secundum atrial septal defect (ASD) and pulmonary hypertension over 60 mm Hg peak pressure, operative indication was determined by morphometric diagnosis of open biopsy of lung specimens. In one patient, open lung biopsy was also performed during corrective surgery. Pulmonary arterial changes in the 15 patients were grouped into four classifications as follow: (1) plexogenic pulmonary arteriopathy (six patients); (2) thromboembolism in small pulmonary arteries (three patients); (3) "musculoelastosis," intimal proliferation of longitudinal smooth muscle bundles and elastic fibers (three patients); and (4) combinations of (1), (2) or (1), (3) (three patients). We conclude concerning the operative indication that group 2 patients are operable in all cases and group 1 patients with Yamaki's index of pulmonary vascular disease of 2.2 or less; group 3 patients with the absence of complete occlusion of the small pulmonary arterial lumen are operable, and patients with clear evidence of severe plexogenic pulmonary arteriopathy in group 4 are not operable. Comparative analysis of pulmonary pathology and hemodynamic performance revealed that open lung biopsy should be performed to determine operative candidacy in cases with a pulmonary vascular resistance greater than 8 unit X m2, which is considered to represent the borderline of operability.

Entities:  

Mesh:

Year:  1987        PMID: 3792083     DOI: 10.1378/chest.91.1.33

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Canadian Cardiovascular Society 2009 Consensus Conference on the management of adults with congenital heart disease: shunt lesions.

Authors:  Candice K Silversides; Annie Dore; Nancy Poirier; Dylan Taylor; Louise Harris; Matthias Greutmann; Lee Benson; Helmut Baumgartner; David Celermajer; Judith Therrien
Journal:  Can J Cardiol       Date:  2010-03       Impact factor: 5.223

2.  Noninvasive assessment of pulmonary vascular resistance and pressure in patients with congenital heart disease: a new method using M-mode echocardiography.

Authors:  Sumito Kimura; Yayoi Nakahata; Takashi Honda; Hisashi Ando; Shohei Ogata; Kazumasa Akiyama; Yoshito Ogihara; Masahiro Ishii
Journal:  J Echocardiogr       Date:  2011-06-11

3.  Indications for thrombolytic therapy in acute pulmonary embolism.

Authors:  J A Dieck; J J Ferguson
Journal:  Tex Heart Inst J       Date:  1989

4.  Pulmonary vascular disease associated with pulmonary hypertension in 445 patients: diagnosis from lung biopsy and autopsy.

Authors:  Shigeo Yamaki
Journal:  Gen Thorac Cardiovasc Surg       Date:  2012-09-26

5.  Transient use of oral bosentan can be an additional option to reduce pulmonary arterial hypertension in a patient with severe pulmonary arterial hypertension associated with atrial septal defect.

Authors:  Yong Kyu Park; Jae-Hyeong Park; Jae Hyeon Yu; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  J Cardiovasc Ultrasound       Date:  2011-09-30

6.  Atrial septal defect with borderline pulmonary vascular disease: surgery and long-term oral prostacyclin therapy for recalcitrant pulmonary hypertension.

Authors:  Hitoshi Yamauchi; Shigeo Yamaki; Masahiro Fujii; Yoshiaki Saji; Masami Ochi; Kazuo Shimizu
Journal:  Jpn J Thorac Cardiovasc Surg       Date:  2004-04
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.